A traditional Chinese medicine combined drug for treating 2,4-dichlorophenoxyacetic acid-induced liver injury of livestock and poultry

By using a specific ratio of proanthocyanidin B3, cryptotanshinone, and resveratrol, the problem of liver damage in livestock and poultry caused by 2,4-dichlorophenoxyacetic acid is solved, significantly improving liver function and antioxidant capacity, and providing a green and safe veterinary liver-protecting drug.

CN122440644APending Publication Date: 2026-07-24HEBEI UNIVERSITY OF ECONOMICS AND BUSINESS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610906701.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-06-23
Publication Date
2026-07-24

Smart Images

  • Figure CN122440644A_ABST
    Figure CN122440644A_ABST
Patent Text Reader

Abstract

The application discloses a traditional Chinese medicine combined medicament for treating 2,4-dichlorophenoxyacetic acid-induced liver injury of livestock and poultry, which is prepared by compounding procyanidin B3, cryptotanshinone and resveratrol, and the three components have synergies and can effectively improve the 2,4-dichlorophenoxyacetic acid-induced liver injury problem of livestock and poultry. The application has simple formula and simple preparation process, can be developed into green and safe liver-protecting veterinary drugs and functional feed, and has good application and popularization value in the field of livestock and poultry breeding.
Need to check novelty before this filing date? Find Prior Art